AMA applauds congressional action on prescription drug transparency

| 1 Min Read

Statement attributable to:
Barbara McAneny, M.D.
President, American Medical Association

“The AMA believes in transparency in prescription drug pricing, and we are pleased the House Ways & Means Committee moved the issue forward. Patients and their physicians want to be armed with more information, yet the current situation is opaque if not impenetrable. The committee is rightfully determined to expose factors that lead to high drug prices, and we look forward to continuing our efforts in that regard.”

Full press statement available when you sign in

Sign in to the AMA website to get the full version of this press statement. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Hands hold a smartphone

More than 80% of physicians use AI professionally: AMA survey

| 4 Min Read
People in a group with stacked hands

Embedding physician well-being into system strategy

| 8 Min Read
Smiling woman works at a laptop

Medicare patients get virtual access to diabetes prevention

| 3 Min Read
Operating room corridor

A more accurate Medicare Advantage provider directory on the way

| 4 Min Read